Apimeds Pharmaceuticals US (APUS) Earnings (2024 - 2026)
Apimeds Pharmaceuticals US (APUS) earnings from Mar 31, 2024 to Mar 31, 2026. The TTM Apimeds Pharmaceuticals US (APUS) earnings is -$41M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Apimeds Pharmaceuticals US (APUS) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +2628.86% |
Annual Earnings change of Apimeds Pharmaceuticals US (APUS)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$35M | +484.33% |
| 2025 | -$6M | +331.65% |
| 2024 | -$1.39M | +78.21% |
| 2023 | -$780K | N/A |